Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

NASDAQ:PHLT - Nasdaq - US71377E1055 - Common Stock - Currency: USD

7.64  +4.09 (+115.21%)

Premarket: 7.7 +0.06 (+0.79%)

Fundamental Rating

4

PHLT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. PHLT has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PHLT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PHLT has reported negative net income.
PHLT had a positive operating cash flow in the past year.
PHLT had negative earnings in each of the past 5 years.
Of the past 5 years PHLT 4 years had a positive operating cash flow.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

PHLT's Return On Assets of -5.66% is on the low side compared to the rest of the industry. PHLT is outperformed by 70.87% of its industry peers.
PHLT has a Return On Equity (-7.63%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.66%
ROE -7.63%
ROIC N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PHLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

8

2. Health

2.1 Basic Checks

PHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHLT has more shares outstanding
The number of shares outstanding for PHLT has been increased compared to 5 years ago.
Compared to 1 year ago, PHLT has a worse debt to assets ratio.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

PHLT has an Altman-Z score of 13.54. This indicates that PHLT is financially healthy and has little risk of bankruptcy at the moment.
PHLT has a Altman-Z score of 13.54. This is amongst the best in the industry. PHLT outperforms 95.15% of its industry peers.
PHLT has a debt to FCF ratio of 1.93. This is a very positive value and a sign of high solvency as it would only need 1.93 years to pay back of all of its debts.
PHLT's Debt to FCF ratio of 1.93 is amongst the best of the industry. PHLT outperforms 82.52% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that PHLT is not too dependend on debt financing.
PHLT's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. PHLT outperforms 73.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.93
Altman-Z 13.54
ROIC/WACCN/A
WACC8.86%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.56 indicates that PHLT has no problem at all paying its short term obligations.
PHLT's Current ratio of 2.56 is amongst the best of the industry. PHLT outperforms 85.44% of its industry peers.
PHLT has a Quick Ratio of 2.56. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PHLT (2.56) is better than 85.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 2.56
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PHLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
Looking at the last year, PHLT shows a quite strong growth in Revenue. The Revenue has grown by 11.76% in the last year.
Measured over the past years, PHLT shows a decrease in Revenue. The Revenue has been decreasing by -3.95% on average per year.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)11.76%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%21.71%

3.2 Future

Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 70.36% on average per year.
The Revenue is expected to grow by 11.37% on average over the next years. This is quite good.
EPS Next Y111.77%
EPS Next 2Y70.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.38%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
PHLT is valuated quite expensively with a Price/Forward Earnings ratio of 65.13.
PHLT's Price/Forward Earnings is on the same level as the industry average.
PHLT is valuated expensively when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 65.13
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

64.08% of the companies in the same industry are cheaper than PHLT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHLT indicates a slightly more expensive valuation: PHLT is more expensive than 61.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 144.06
EV/EBITDA 386.46
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PHLT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHLT's earnings are expected to grow with 70.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PHLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (8/1/2025, 8:00:00 PM)

Premarket: 7.7 +0.06 (+0.79%)

7.64

+4.09 (+115.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners81.32%
Inst Owner ChangeN/A
Ins Owners4.48%
Ins Owner Change-5.87%
Market Cap598.29M
Analysts82.22
Price Target7.4 (-3.14%)
Short Float %1.48%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.35%
Min EPS beat(2)41.19%
Max EPS beat(2)173.52%
EPS beat(4)4
Avg EPS beat(4)59.56%
Min EPS beat(4)1.96%
Max EPS beat(4)173.52%
EPS beat(8)7
Avg EPS beat(8)75.85%
EPS beat(12)11
Avg EPS beat(12)65.12%
EPS beat(16)14
Avg EPS beat(16)59.12%
Revenue beat(2)1
Avg Revenue beat(2)4.41%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)9%
Revenue beat(4)2
Avg Revenue beat(4)2.21%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)9%
Revenue beat(8)5
Avg Revenue beat(8)1.59%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)10
Avg Revenue beat(16)2.24%
PT rev (1m)3.57%
PT rev (3m)3.57%
EPS NQ rev (1m)-11.13%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 65.13
P/S 4.64
P/FCF 144.06
P/OCF 66.77
P/B 7.66
P/tB 19.45
EV/EBITDA 386.46
EPS(TTM)-0.06
EYN/A
EPS(NY)0.12
Fwd EY1.54%
FCF(TTM)0.05
FCFY0.69%
OCF(TTM)0.11
OCFY1.5%
SpS1.65
BVpS1
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.66%
ROE -7.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 3.22%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.93
Debt/EBITDA 5.18
Cap/Depr 72.28%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 580.75%
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 2.56
Altman-Z 13.54
F-Score5
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y111.77%
EPS Next 2Y70.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.76%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%21.71%
Revenue Next Year9.38%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y9.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y199.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2458.16%
OCF growth 3Y88.66%
OCF growth 5YN/A